Morphine maintenance treatment in opiate dependent patients;Tratamiento con morfina en la dependencia de opiáceos

Revista Clinica Espanola

Volumn 207, Issue 4, 2007, Pages 194-196

  Roncero Alonso, C ^a   Saez Francas N ^a   Castells Cervello X ^a   Casas Brugue M ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; CANNABIS; METHADONE; MORPHINE; NICOTINE;

ALCOHOLISM; CANNABIS SMOKING; COCAINE DEPENDENCE; DRUG EFFICACY; DRUG TOLERABILITY; HEROIN DEPENDENCE; HUMAN; OPIATE ADDICTION; REVIEW;

EID: 34249789005     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13101850     Document Type: Article

References (17)

1. Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G. Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction. 2005;100:1101-9.
2. Kraigher D, Jagsch R, Gombas W, Ortner R, Eder H, Primorac A, et al. Use of slow-release morphine for the treatment of opioid dependence. Eur Addict Res. 2005;11:145-51.
3. Vocci FJ, Acri J, Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry. 2005;162:1432-40.
4. Woody GE. New horizons: sustained morphine as agonist treatment. Addiction. 2005;100:1758-9.
5. Roncero C, Sáez N, Castells X, Casas M. Eficacia de la buprenorfina. Trastornos Adictivos. En prensa 2006.
6. Ferri M, Davoli M, Perucci CA. Heroin maintenance for chronic heroin dependents. Cochrane Database Syst Rev. 2005;18(2):CD003410.
7. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589-94.
8. Bochner F, Somogyi AA, Christrup LL, Larsen LI, Danz C, Elback K. Comparative pharmacokinetics of two modified release oral morphine formulations (Reliadol and Kapanol) and an immediate release morphine tablet (Morfin 'DAK') in healthy volunteers. Clin Drug Invest. 1999;17:59-66.
9. Mitchell T, White J, Somogyi A, Bochner F. Slow- release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction. 2004;99:940-5.
10. Kraigher D, Ortner R, Eder H, Schindler S, Fischer G. Slow-release morphine hydrochloride for maintenance therapy of opioid dependence. Wiene Klinische Wochenschrift. 2002;114:904-10.
11. Giacomuzzi S, Kemmler G, Ertl M, Riemer Y. Opioid addicts at admission vs slow-release oral morphine, methadone and sublingual buprenorphine maintenance treatment participants. Subst Use Misuse. 2006;41:223-44.
12. Mercadante S, Casuccio A, Calderone L. Rapad switching from morphine to methadone in cancer patients with poor response to morphine. J Clin Oncol. 1999;17:3307-12.
13. Vasilev G, Alexieva D, Pavlova R. Safety and efficacy of oral slow release morphine for maintenance treatment in heroin addicts: A 6-month open noncomparative study. Eur Addict Res. 2006;12:53-60.
14. Mitchell TB, White JM, Somogyi AA, Bochner F. Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence. Drug Alcohol Dependend. 2003;72:85-94.
15. Giacomuzzi SM, Ertl M, Vigil A, Riemer Y, Günther V. Driving capacity of patients treated with methadone and slow-release oral morphine. Addiction. 2005;100:1027.
16. Hardman JG, Limbird LE, Gilman AG. Goodman and Gilman's The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001.
17. Flórez J. Fármacos analgésicos opioides. En: Flórez J. Farmacología humana. 4th ed. Barcelona: Masson; 2003.